Clinical Trials Directory

Trials / Completed

CompletedNCT00808054

Evaluation of Analgesia With EMLA and Glucose Oral Solution

Evaluation of Analgesia With the Use of Eutectic Mixture of Local Anesthetics (Lidocaine and Prilocaine) and Oral Solution of Glucose to 25% in Preterm Neonates During Arterial Puncture and / or the Installation of Percutaneous Catheter

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Federal University of Minas Gerais · Academic / Other
Sex
All
Age
1 Hour – 7 Days
Healthy volunteers
Accepted

Summary

In this randomized controlled study the investigators intended to compare analgesic effects of EMLA and/or oral glucose in 60 preterm neonate during arterial function and PICC installation.

Detailed description

It is a randomised controlled clinical trial, double blinded, with the purpose to compare the use of eutectic mixture of local anesthetics (lidocaine and prilocaine) and/or the oral solution of glucose 25% in the prevention and treatment of pain in preterm neonates with gestational between 28-37 weeks old. The pain evaluation will be done using NIPS scale, and also physiologic variables (HR, MAP, oxygen saturation level and crie) during two painful procedures performed in the neonatal intensive care units:arterial puncture (n=30) and peripherally inserted central catheters (n=30). All procedures will have clinical indication and will not be implemented by the researcher.The newborns will be randomized into three groups: A (EMLA and glucose; n=20),B (EMLA AND placebo; n=20) and C (anesthetic cream placebo and oral glucose; n=20). All newborns will be subjected to some kind of therapeutic intervention, the objective of this study is validate the application of control measures and treatment of pain for these two procedures that cause mild and moderate pain.

Conditions

Interventions

TypeNameDescription
DRUGEMLA0.5g topical EMLA

Timeline

Start date
2008-11-01
Primary completion
2009-12-01
Completion
2009-12-01
First posted
2008-12-15
Last updated
2014-07-25

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT00808054. Inclusion in this directory is not an endorsement.